Level of miR-125B and miR-451 and Deregulated Expression of PI3K/AKT/mTOR Pathway in Gastric Cancer

被引：0
|
作者：
Tapia, O. [1 ]
Riquelme, I. [1 ]
Sandoval, A. [1 ]
Letelier, P. [1 ]
Leal, P. [1 ]
Roa, J. C. [1 ]
机构：
[1] Univ La Frontera, Temuco, Chile
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
750
引用
收藏
页码：182A / 182A
页数：1
相关论文
共 50 条
  • [41] Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk
    Ge, Yuqiu
    Liu, Hanting
    Qiu, Xiaonan
    Ma, Gaoxiang
    Wang, Haixiao
    Du, Mulong
    Wang, Meilin
    Zhao, Qinghong
    Tao, Guoquan
    Chu, Haiyan
    Zhang, Zhengdong
    GENE, 2018, 670 : 130 - 135
  • [42] MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer
    Jiang, K.
    Xie, L-F
    Xiao, T-Z
    Qiu, M-Y
    Wang, W-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (20) : 8861 - 8869
  • [43] MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer
    Lu, Wei-Dong
    Zuo, Yun
    Xu, Zhen
    Zhang, Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4564 - 4573
  • [44] MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer
    Lu, Weidong
    Xu, Zhen
    Zhang, Min
    Zuo, Yun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 7286 - 7296
  • [45] Effects of miR-21 on hypertensive rats through PTEN/PI3K/Akt/mTOR signaling pathway
    Shi, Y. J.
    Xu, W.
    Han, Y-F
    Li, J-X
    Niu, L-L
    Chen, Y-D
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (11) : 4924 - 4931
  • [46] PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
    Fattahi, Sadegh
    Amjadi-Moheb, Fatemeh
    Tabaripour, Reza
    Ashrafi, Gholam Hossein
    Akhavan-Niaki, Haleh
    LIFE SCIENCES, 2020, 262
  • [47] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [48] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [49] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [50] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216
12345